How do antiphospholipid antibodies bind β2-glycoprotein I?

被引：43

作者：

Giles, IP

Isenberg, DA

Latchman, DS

Rahman, A

机构：

[1] UCL, Ctr Rheumatol, London W1T 4NJ, England

[2] UCL, Inst Child Hlth, London W1T 4NJ, England

来源：

ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 08期

关键词：

D O I：

10.1002/art.11101

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2111 / 2121

页数：11

共 96 条

[1] LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus -: Results from a randomized, double-blind, placebo-controlled study [J].

Alarcón-Segovia, D ;

Tumlin, JA ;

Furie, RA ;

McKay, JD ;

Cardiel, MH ;

Strand, V ;

Bagin, RG ;

Linnik, MD ;

Hepburn, B .

ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :442-454

[2] ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE ANALYSIS OF 500 CONSECUTIVE PATIENTS [J].

ALARCONSEGOVIA, D ;

DELEZE, M ;

ORIA, CV ;

SANCHEZGUERRERO, J ;

GOMEZPACHECO, L ;

CABIEDES, J ;

FERNANDEZ, L ;

DELEON, SP .

MEDICINE, 1989, 68 (06) :353-365

[3]

ALARCONSEGOVIA D, 1994, J RHEUMATOL, V21, P982

[4] Antibodies to high-density lipoprotein and β2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome [J].

Alves, JD ;

Ames, PRJ ;

Donohue, S ;

Stanyer, L ;

Noorouz-Zadeh, J ;

Ravirajan, C ;

Isenberg, DA .

ARTHRITIS AND RHEUMATISM, 2002, 46 (10) :2686-2694

[5] Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies [J].

Ames, PRJ ;

Margarita, A ;

Alves, JD ;

Tommasino, C ;

Iannaccone, L ;

Brancaccio, V .

LUPUS, 2002, 11 (04) :208-214

[6] MEASUREMENT OF ANTIPHOSPHOLIPID ANTIBODIES BY ELISA USING BETA-2-GLYCOPROTEIN-I AS AN ANTIGEN [J].

ARVIEUX, J ;

ROUSSEL, B ;

JACOB, MC ;

COLOMB, MG .

JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 143 (02) :223-229

[7] THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES [J].

ASHERSON, RA ;

KHAMASHTA, MA ;

ORDIROS, J ;

DERKSEN, RHWM ;

MACHIN, SJ ;

BARQUINERO, J ;

OUTT, HH ;

HARRIS, EN ;

VILARDELLTORRES, M ;

HUGHES, GRV .

MEDICINE, 1989, 68 (06) :366-374

[8] ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES - A MARKER OF ANTIPHOSPHOLIPID SYNDROME [J].

BALESTRIERI, G ;

TINCANI, A ;

SPATOLA, L ;

ALLEGRI, F ;

PRATI, E ;

CATTANEO, R ;

VALESINI, G ;

DELPAPA, N ;

MERONI, P .

LUPUS, 1995, 4 (02) :122-130

[9] Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides [J].

Blank, M ;

Shoenfeld, Y ;

Cabilly, S ;

Heldman, Y ;

Fridkin, M ;

Katchalski-Katzir, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5164-5168

[10] INDUCTION OF ANTIPHOSPHOLIPID SYNDROME IN NAIVE MICE WITH MOUSE LUPUS MONOCLONAL AND HUMAN POLYCLONAL ANTICARDIOLIPIN ANTIBODIES [J].

BLANK, M ;

COHEN, J ;

TODER, V ;

SHOENFELD, Y .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) :3069-3073

← 1 2 3 4 5 6 7 8 9 10 →